Explore Mazdutide dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Mazdutide (IBI362 / LY3305677) is a GLP-1 and glucagon receptor dual agonist based on the oxyntomodulin backbone, developed by Innovent and Eli Lilly and studied in the GLORY program for obesity and type 2 diabetes. Its glucagon arm adds an energy-expenditure component on top of GLP-1-driven appetite suppression. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting Mazdutide.
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.